Regulatory and Washington

05/20/2011 - 11:48am

The Food and Drug Administration has approved a new antiretroviral treatment for HIV made by Johnson & Johnson, the agency said Friday.

05/20/2011 - 11:22am

A Food and Drug Administration advisory committee has voted to recommend that the FDA retain approval of an Abbott drug for high cholesterol in combination with a statin.

05/20/2011 - 11:17am

The Louisiana State Senate passed legislation that would expand the authority given to pharmacists to administer immunizations.

05/20/2011 - 10:37am

Swimmer’s ear accounts for as many as 2.4 million doctor visits and nearly $500 million in healthcare costs annually, a Centers for Disease Control and Prevention report published Thursday in its "Morbidity and Mortality Weekly Report" found.

05/20/2011 - 10:27am

Sandoz is looking to market a generic version of a Shire drug for treating attention deficit hyperactivity disorder.

05/20/2011 - 10:22am

The Council for Responsible Nutrition on Thursday issued a statement regarding the growing controversy surrounding Lazy Cakes — a brownie containing melatonin, an ingredient that helps establish more normal sleeping patterns — that has been cited in a New York Times article as having “flagrantly mimic[ked] the soothing effects of hash brownies.”

05/19/2011 - 11:35am

Theodore Kaczynski, also known as the Unabomber, allegedly is a suspect in the 1982 Tylenol poisonings in the Chicago area that killed seven people, according to published reports.

05/19/2011 - 11:05am

The Centers for Disease Control and Prevention posted an attention-grabbing page Wednesday titled: “Preparedness 101: Zombie Apocalypse.”

05/19/2011 - 10:43am

A controversial GlaxoSmithKline drug for treating Type 2 diabetes no longer will be available through retail pharmacies as of Nov. 18, the Food and Drug Administration announced Wednesday.

05/19/2011 - 10:12am

The National Retail Federation on Wednesday launched a 60-day lobbying, grassroots and media campaign aimed at ensuring that a new federal law — which is designed to save retailers and their customers more than $1 billion a month by lowering the “swipe fees" banks charge to process debit card transactions — takes effect in late July as scheduled.